Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

What Hedge Funds Think About Covance Inc. (CVD)

Page 1 of 2

If you were to ask many of your peers, hedge funds are viewed as overrated, outdated financial tools of a period lost to current times. Although there are more than 8,000 hedge funds in operation in present day, Insider Monkey aim at the moguls of this club, around 525 funds. It is assumed that this group oversees the lion’s share of all hedge funds’ total assets, and by tracking their best stock picks, we’ve discovered a few investment strategies that have historically outstripped the S&P 500. Our small-cap hedge fund strategy beat the S&P 500 index by 18 percentage points a year for a decade in our back tests, and since we’ve began to sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 33 percentage points in 11 months (find a sample of our picks).

Covance Inc. (NYSE:CVD)

Equally as useful, optimistic insider trading sentiment is a second way to analyze the stock market universe. As the old adage goes: there are a variety of reasons for a bullish insider to drop shares of his or her company, but just one, very clear reason why they would behave bullishly. Plenty of empirical studies have demonstrated the impressive potential of this tactic if investors understand what to do (learn more here).

Now that that’s out of the way, we’re going to study the recent info for Covance Inc. (NYSE:CVD).

What have hedge funds been doing with Covance Inc. (NYSE:CVD)?

At Q2’s end, a total of 15 of the hedge funds we track were bullish in this stock, a change of 0% from one quarter earlier. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of noteworthy hedge fund managers who were upping their holdings substantially.

Out of the hedge funds we follow, Columbus Circle Investors, managed by Donald Chiboucis, holds the biggest position in Covance Inc. (NYSE:CVD). Columbus Circle Investors has a $28.8 million position in the stock, comprising 0.2% of its 13F portfolio. On Columbus Circle Investors’s heels is Chuck Royce of Royce & Associates, with a $24.6 million position; 0.1% of its 13F portfolio is allocated to the company. Remaining hedge funds that are bullish include Brian Ashford-Russell and Tim Woolley’s Polar Capital, D. E. Shaw’s D E Shaw and Cliff Asness’s AQR Capital Management.

Because Covance Inc. (NYSE:CVD) has faced bearish sentiment from the smart money’s best and brightest, it’s easy to see that there was a specific group of hedgies that slashed their entire stakes heading into Q2. Intriguingly, Israel Englander’s Millennium Management dropped the biggest investment of the “upper crust” of funds we watch, comprising close to $16.6 million in call options., and Israel Englander of Millennium Management was right behind this move, as the fund said goodbye to about $4.4 million worth. These transactions are intriguing to say the least, as total hedge fund interest stayed the same (this is a bearish signal in our experience).

How have insiders been trading Covance Inc. (NYSE:CVD)?

Insider buying is best served when the company in focus has seen transactions within the past half-year. Over the latest half-year time frame, Covance Inc. (NYSE:CVD) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also review the relationship between both of these indicators in other stocks similar to Covance Inc. (NYSE:CVD). These stocks are Laboratory Corp. of America Holdings (NYSE:LH), Alere Inc (NYSE:ALR), PAREXEL International Corporation (NASDAQ:PRXL), Mettler-Toledo International Inc. (NYSE:MTD), and PerkinElmer, Inc. (NYSE:PKI). All of these stocks are in the medical laboratories & research industry and their market caps resemble CVD’s market cap.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!